A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls

NCT07217886 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: S-892216-PO

Sponsor

Shionogi

Collaborators

[object Object]